Quick Answer: GLP-1 medications originated from exendin-4, a peptide discovered in Gila monster venom that mimics human GLP-1 hormone with enhanced stability, leading to FDA-approved diabetes treatments
Talk to a provider who understands Laura Heffern, Weight Loss NP Personalized treatment plans for metabolic health disorders and optimization
Tirzepatide, followed by semaglutide, is the most likely to cause nausea and vomiting
Further studies are needed to assess the potential cardiovascular and renal benefits of combination therapy and to determine suitable patient population for the therapy
A maintenance strategy matters: nutrition, resistance training, follow-up, medication adjustment, dose reduction, switching, or continued therapy depending on the patient
Not all platforms offer round-the-clock provider access